We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. (REGN) on Notes From The Beauty Contest’s Substack. In ...

Cardinal Health's growth faces challenges from tariff risks, regulatory uncertainties, and competitive pressures. Learn more ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals ...

Expanding hospital-based pharmacies may increase medication adherence, reduce hospital admissions, improve access and ...

Discover trends shaping the pharmaceutical sector. Get insights on rising prescription drug prices, supply chains, and growth ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed, could worsen ...

For investors still seeking companiies with attractive long-term prospects, let's consider two in the biotech industry: ...

Analysts have set 12-month price targets for Regeneron Pharmaceuticals, revealing an average target of $808.67, a high ...

“This is not a prescription drug affordability bill,” said Lori Reimers, lobbyist for the Pharmaceutical Care Management ...

Guangzhou Pharmaceutical Holdings Limited (GPHL), a Fortune Global 500 company, has taken a significant step forward in its ...

The pharmaceutical-grade sodium chloride market is projected to be valued at USD 355 million in 2024 and is expected to grow at a CAGR of 5.70% from 2024 to 2034, reaching USD 618 million by 2034.